Eli Lilly (LLY)
868.53
+0.26 (0.03%)
NYSE · Last Trade: Apr 28th, 3:26 PM EDT
What Happened? Shares of personal wellness company WeightWatchers (NASDAQ:WW) fell 5.3% in the afternoon session after the company announced its intention to...
Via StockStory · April 28, 2026
Via MarketBeat · April 28, 2026
The drugmaker is getting on the AI train in ways that could move the needle down the road.
Via The Motley Fool · April 27, 2026
Eli Lilly has more to offer than some investors realize.
Via The Motley Fool · April 27, 2026
Hims & Hers stock rallied on Friday on a major regulatory update and bullish analyst note. Here’s how high HIMS shares could realistically fly through the end of 2026.
Via Barchart.com · April 27, 2026
Eli Lilly shares sink as data shows Foundayo trailing Novo’s oral Wegovy. But there’s reason to consider buying LLY shares on the dip today.
Via Barchart.com · April 27, 2026
This pharma stock is cheap for a reason.
Via The Motley Fool · April 27, 2026
This space stock could literally go "to the moon."
Via The Motley Fool · April 27, 2026
With more focus on nuclear energy, companies connected to nuclear power could be strong long-term investments.
Via The Motley Fool · April 26, 2026
Most investors currently see the glass on this stock as being half-empty. Analysts, however, still view the glass as at least half-full.
Via The Motley Fool · April 26, 2026
Eli Lilly is a giant in the weight-loss drug realm, and it's aiming to grow more.
Via The Motley Fool · April 25, 2026
You get the upside of the sector, while minimizing some of the risks.
Via The Motley Fool · April 25, 2026
The weight loss drug market may reach almost $100 billion in a few years.
Via The Motley Fool · April 25, 2026
High hopes for a freshly approved drug might not be realized, if early data is any indication.
Via The Motley Fool · April 24, 2026
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.6% in the afternoon session after disappointing weekly prescription number...
Via StockStory · April 24, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · April 24, 2026
Major M&A deals this week include Eli Lilly buys Kelonia for $7 billion, Honeywell sells PSS to Brady Corp., KSL buys Invited Clubs.
Via Benzinga · April 24, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · April 24, 2026
Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new obesity pill, Foundayo.
Via Investor's Business Daily · April 24, 2026
Young adults with median earnings can build sizable portfolios by retirement by regularly purchasing shares of the Vanguard S&P 500 Growth ETF.
Via The Motley Fool · April 24, 2026
Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded pharmaceuticals earnings season. Looking...
Via StockStory · April 23, 2026
Federated Hermes delivers asset management solutions across equity, fixed income, and money market funds to a diverse client base.
Via The Motley Fool · April 23, 2026
Amazon is expanding into integrated weight-loss care with a scalable healthcare model. Can this expansion meaningfully drive AMZN stock upside?
Via Barchart.com · April 23, 2026
Novo Nordisk stock has been stuck in a downward spiral for quite some time.
Via The Motley Fool · April 23, 2026
Hims & Hers Health can now connect its customers with self-pay prices for Eli Lilly's weight-loss drugs.
Via Investor's Business Daily · April 23, 2026